Medicare Drug Price Cuts Pull Down Publix Same-Store Sales
Florida grocers with prescription-heavy revenue should expect same-store sales pressure as the Medicare maximum fair price change takes hold.
Updated on Nov. 2, 2026 in Economic Indicators
Live Poll
Are you spending less on groceries than you did a year ago?
Publix Super Markets reported third-quarter comparable-store sales down 0.6% for the period ended Sept. 26, even as total quarterly sales rose 1% to $15.5 billion. The decline was attributed primarily to the Medicare maximum fair price change, which took effect Jan. 1, 2026, and broader economic conditions affecting consumer spending.
Why it matters
For grocers and pharmacy-adjacent retailers in Florida and across the Southeast, the result shows that lower federal drug pricing can pull down same-store revenue even when total sales grow. Operators should expect prescription-heavy revenue lines to compress as pricing rules change, while overall store traffic and new-location growth continue to carry top-line totals.
Publix reported Q3 sales of $15.5 billion, up 1% from $15.4 billion a year earlier, while comparable-store sales fell 0.6%. Q3 net earnings declined 9.9% to $1.1 billion, and the company's nine-month comparable-store sales decreased 0.4%.
The players
Publix Super Markets
Florida-headquartered supermarket chain operating across the Southeast, known for its employee-owned structure and a stock that is not publicly traded.
Medicare
The federal health insurance program for older Americans and people with disabilities, whose drug pricing rules directly affect pharmacy revenue for retailers.
The details
The Medicare maximum fair price change, effective Jan. 1, 2026, reduced the prices that apply to 10 drugs, which lowers the dollar value of prescription sales at pharmacies that fill those prescriptions. Because comparable-store sales exclude new locations, a price reduction on high-volume drugs flows directly into the same-store figure. Publix attributed the Q3 comparable-store decline primarily to this pricing change and to economic conditions affecting consumer spending.
Timeline
Jan. 1, 2026: Medicare maximum fair price change took effect, reducing prices for 10 drugs.
Sept. 26, 2026: Publix's third quarter ended, with reported sales and earnings.
Oct. 7, 2026: Publix opened a store in Florence, Kentucky.
Oct. 28, 2026: Publix opened a supermarket in Independence, Kentucky.
Nov. 1, 2026: Publix stock price adjusted to $18.70 per share from $19.60.
Market Landscape
The Inflation Reduction Act's Medicare drug-price negotiation provisions set the pricing framework now reshaping pharmacy revenue at large grocery chains. Publix's comparable-store decline is one of the clearer early readings of how that framework shows up in retail sales.
Florida pharmacy and grocery operators should model prescription revenue under the Medicare maximum fair price schedule for the 10 affected drugs and review how much of their same-store sales depends on those lines. Finance and procurement teams should also watch comparable-store trends separately from total sales growth, since new-store openings can mask same-store softness.
The takeaway
Operators should treat comparable-store sales, not total sales, as the cleaner signal of underlying demand when drug pricing rules change. Track the next quarterly filing for whether the Medicare pricing effect persists in the comparable-store line or fades as the price change annualizes.
Further reading
For broader context on the readings that track consumer spending and retail activity, see Economic Indicators coverage for Florida.
Live Poll
Are you spending less on groceries than you did a year ago?
